NCT00618293View on ClinicalTrials.gov

Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2011

Conditions
Blood Loss, Surgical
Interventions
DRUG

Haemate HS

intravenous infusion of Haemate (dosage dependent on body weight)

OTHER

NaCl-solution

intravenous infusion of 0.9%NaCl-Solution

Trial Locations (1)

40225

Klinik für Kardiovaskuläre Chirurgie, Düsseldorf

Sponsors

Collaborators (1)

CSL Behring
All Listed Sponsors
collaborator

CSL Behring

INDUSTRY

lead

Heinrich-Heine University, Duesseldorf

OTHER